Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide

Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide

US Patent 10981973 · Granted Apr 20, 2021

Estimated economic value: $36,217,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for producing levulinic acid2025
Cache circuit that selectively stores data blocks to dynamically optimize for re2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Proteins binding NKG2D, CD16 and a tumor-associated antigen2025
Methods for treating heterotopic ossification2025
ALK7 binding proteins and uses thereof2025
ALK7 binding proteins and uses thereof2025